| Value | ₹148.7 Cr |
|---|
BSE filing, NSE: ASTRAZEN. Summary written from the filing by ALFA Finder's alert engine.
AstraZeneca Pharma India Ltd: key numbers
- Share price
- ₹6,279.50
- Market cap
- ₹15,699 Cr
- Revenue (annual)
- ₹2,276 Cr
- Net profit (annual)
- ₹187.5 Cr
- P/E (TTM)
- 92.5×Sector 46.1×
- Promoter holding
- 75.00%+0.00% QoQ
- FII holding
- 2.64%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from AstraZeneca Pharma India Ltd
All →AstraZeneca Pharma India Capacity Expansion
AstraZeneca Pharma India inaugurated a new corporate office in Mumbai, covering 25,600 sq ft. This expansion strengthens the company's commercial operations and footprint in India.
- office space
- 25600.0 sq ft
AstraZeneca Pharma India Annual General Meeting
AstraZeneca Pharma India Ltd declared the voting results of its postal ballot, confirming the appointment and designation change of certain non-executive directors.
AstraZeneca Pharma India Other Announcement
NSE Sustainability Ratings and Analytics assigned AstraZeneca Pharma India an ESG rating of 73 for FY 2025-26. The rating was independently prepared without company engagement.
AstraZeneca Pharma India Legal & Regulatory
AstraZeneca Pharma India Limited received an order from the ROC, Bengaluru, imposing a total penalty of ₹0.03 Crore for a delayed filing. The company is evaluating next steps.
- Value
- ₹0.03 Cr
- From
- Registrar of Companies, Bengaluru, Karnataka
AstraZeneca Pharma India Legal & Regulatory
AstraZeneca Pharma disclosed a ₹1.88 lakh penalty from the Registrar of Companies due to a delay in filing Form MR-2.
- Value
- ₹0.02 Cr
AstraZeneca Pharma India Management Change
AstraZeneca Pharma India's Dr. Sandeep Arora resigned as Director, Medical Affairs, effective September 15, 2026. The company is seeking a suitable replacement for the position.
Other legal & regulatory announcements
All →Sanco Trans Legal & Regulatory
Sanco Trans received Customs orders under Sections 75 and 114 for alleged wrong duty drawback availment by exporters. If accepted, recovery, interest and penalty total Rs 5.80 Lakhs, which the company will contest.
- Value
- ₹0.06 Cr
Indo Amines Legal & Regulatory
Indo Amines disclosed a GST search under Maharashtra GST Act Section 67, concluded October 28, 2026. No material impact on operations or financials was reported.
Delta Corp Legal & Regulatory
CGST Goa rectified GST orders reducing Delta Corp's differential demand to ₹28.99 Crore for casino-entry packages (2017-22). Company may appeal the remaining penalty within prescribed timelines.
- Value
- ₹28.99 Cr
Jammu & Kashmir Bank Legal & Regulatory
J&K Bank announces CBIC GST circular validates its FTP position, supporting quashing of two demand orders. Total GST liability at stake is ₹8,330.87 Crore.
- Value
- ₹8,331 Cr
Shera Energy Legal & Regulatory
Shera Energy disclosed an NSE advisory letter for ICDR Reg 160(f) non-compliance on delayed warrant conversion filing. No monetary penalty was levied.
Abril Paper Tech Legal & Regulatory
April Paper Tech disclosed a personal hearing on 02 Nov 2026 on a GST show-cause notice alleging short tax payment. The company considers the demand unmaintainable and expects no financial impact.